Market Overview

The Cooper Companies Expands Share Buyback Program by $200M

Related COO
Top 4 Mid-Cap Stocks In The Medical Instruments & Supplies Industry With The Highest EPS
Dow Flirts With 17,000, S&P 500 Inches Closer To 2,000 In First Trading Day Of The Third Quarter

The Cooper Companies, Inc. (NYSE: COO) today announced that its Board of Directors has authorized the repurchase of up to an additional $200.0 million of common stock under the existing share repurchase program. With this approval the Company is now authorized to repurchase up to $500.0 million of its common stock. The program has $261.5 million of remaining availability and no expiration date.

About The Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 8,000 employees with products sold in over 100 countries. For more information, please visit

Forward-Looking Statements

This news release contains "forward-looking statements" as defined by

See full press release

Posted-In: News Guidance Dividends Contracts Buybacks Management Global


Most Popular

Related Articles (COO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free